AMLX · Amylyx Pharmaceuticals, Inc.
$37.08
-0.38 (-1.01%)
At close · Aug 26
Market Cap
$4.13B
Shares
111.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-20 | 2026-08-19 | |
| 8-K | 2026-08-18 | — | |
| 8-K | 2026-08-18 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-08-06 | — | |
| 8-K | 2026-06-04 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| 8-K | 2026-03-24 | — | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-01-08 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-09-10 | 2025-09-09 | |
| 8-K | 2025-08-27 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-06-05 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-24 | 2025-06-05 | |
| 10-K | 2025-03-04 | 2024-12-31 | |
| 8-K | 2025-03-04 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-30 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-17 | — | |
| 8-K | 2024-08-08 | — | |
| 10-Q | 2024-08-08 | 2024-06-30 | |
| 8-K | 2024-07-10 | 2024-07-09 | |
| 8-K | 2024-06-21 | — | |
| 8-K | 2024-06-06 | — | |
| 8-K | 2024-05-09 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| DEF 14A | 2024-04-24 | 2024-06-06 | |
| 8-K | 2024-04-10 | — | |
| 8-K | 2024-04-04 | 2024-04-03 | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-03-08 | — | |
| 8-K | 2024-02-22 | — | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2023-12-07 | — | |
| 10-Q | 2023-11-09 | 2023-09-30 | |
| 8-K | 2023-11-09 | — | |
| 8-K | 2023-10-13 | — | |
| 10-Q | 2023-08-10 | 2023-06-30 | |
| 8-K | 2023-08-10 | — |
Showing 1–50 of 78 filings
Key facts
CIK
1658551
CUSIP
03237H101
13F (30d)
188 filings
188 filers
Visit website
Investor relations